Immunotech Biopharm Ltd. has announced the resignation of Dr. Wang as Executive Director, Chief Executive Officer, and Chief Technology Officer, effective June 25, 2025. The company's board, chaired by Mr. Tan Zheng, maintains that the allegations in Dr. Wang's resignation letter are unfounded. Other board members include Ms. Yu Xiaohui, Mr. Wang Ruihua, Mr. Yang Fan, and Mr. Wang Donghu as non-executive directors, with Professor Wang Yingdian, Mr. Ng Chi Kit, and Ms. Peng Sujiu serving as independent non-executive directors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.